Spontaneous adverse event notifications by patients subsequent to the marketing of a new formulation of Levothyrox((R)) amidst a drug media crisis: atypical profile as compared with other drugs. - Viard, D; Parassol-Girard, N; Romani, S (2018)
doi:10.1111/fcp.12446. doi:10.1111/fcp.12446